Basic Details Of Mangalam Global Enterprise Ltd IPO

Mangalam Global Enterprise Limited is a castor oil manufacturing company. It also engaged in the production of delineating cotton and cotton bales. The cotton and castor manufacturing units located in Harij, Gujarat, and Palanpur. The company is planning to go public through the IPO. So, it launches the Mangalam Global IPO on 5th November. It is completely a fresh issue. The issue will close for subscription on 20th November 2019.

Issue Dates	Nov 15, 2019 – Nov 20, 2019
Issue Type	Fixed Price Type Issue
IPO Size	4, 230, 000 shares of face value Rs 10 per eq share aggregating up to Rs 21.57 crore
Issue Price	Rs 51 per Equity Share
Minimum Bid & Lot Size	2000 shares
Listing	NSE SME

Objects Of The Scheme

In its draft papers, it is said that the funds raised through the issue will utilize towards working capital requirements, general corporate purpose, and issue expenses.

The IPO offers a total of 4,230,000 equity shares aggregating up to Rs 21.57 crore. It has been set an issue price at Rs 51 per share of face value Rs 10 per equity share. The minimum order size and market lot size set at 2000 shares. Investors require to buy a minimum of 2000 shares per request. As of the report, the issue reserves 50 percent of shares to the retail investors. Mangalam IPO comprises only a fresh issue of 42,30,000 shares.

The proposed issue will list on NSE SME platform. The issue will manage by Panthomath Capital Advisor Pvt Ltd. 

Promoter Holding

Pre Issue Share Holding	96.38%
Post Issue Share Holding	70.99%

The Castor oil making company’s forthcoming public issue fixed a market lot size and the amount for retail investors. The retail investors should buy a minimum of 2000 shares worth of Rs 102,000. 

Experts View:

Certified market experts said that the business of forthcoming public offer firm depends on seasonal requirements. Moreover, the company leading the venture of common disasters. Finally, the experts suggest that investors should apply at their own risk.

Disclaimer: This article just offers data about the public issue. It does not grant any advice or direction to invest. Please study the proposal paper thoughtfully and consult your adviser before investing.

Write a Review

Submit Review